Key result
ICD-10 substance use codes demonstrated high specificity and positive predictive value but low sensitivity, with the opioid code (F11) yielding a sensitivity of 42.6%.
Why the study?
Healthcare databases offer epidemiological research potential in people who inject drugs, but the validity of ICD-10 codes for specific substances in this population has not been assessed.
Are ICD-10 substance use codes valid for identifying specific substance use in patients with infective endocarditis?
Cohort (n=379)
Yes
Are ICD-10 substance use codes valid for identifying specific substance use in patients with infective endocarditis?
ICD-10 substance use codes in endocarditis patients have high specificity and PPV but low sensitivity, requiring adjustment for low sensitivity if used in research.
Answers are grounded in this paper and cite their sources.
ICD-10 substance codes show high specificity but low sensitivity in endocarditis; leaves open need for supplementary methods in research and surveillance.
Background: Healthcare databases have the potential to become efficient tools for epidemiological research in People Who Inject Drugs (PWID). The validity of ICD-10 codes for specific substances in this population has not been assessed.Objectives: Validate ICD-10 diagnosis codes relating to the use of specific substance classes in a cohort of endocarditis patients.Methods: Our study sample consisted of 379 first-episode infective endocarditis patients (Male: 208, Female: 171), aged 18–55, admitted to any of three hospitals in London, Ontario from 2007 to 2018. Of these, 287 used drugs. We validated ICD-10 substance use codes for opioids (F11), stimulants (F15), cocaine (F14) and multiple substances (F19). Sensitivity, specificity, Positive Predictive Value (PPV) and Negative Predictive Value (NPV) were calculated for each code, using self-reported substance use documented on medical record review as a gold standard. We conducted a comparative analysis between code-negative users and code-positive users for each substance.Results: All substance use codes shared the same pattern: high specificity, high PPV and low sensitivity, with code F11 yielding the highest PPV (96.3%; 95% C.I.: 90.8–98.6) and sensitivity (42.6%; 95% C.I. 36.3–49.1). The code-positives and code-negatives for each substance did not differ significantly in any characteristics compared.Conclusion: Our results suggest that the individual ICD-10 codes analyzed should not be used for research without adjustment for low sensitivity. However, due to high PPV and specificity, these codes may still have potential for research use. Because code-negative patients did not differ from code-positive patients, their data may be extrapolated to the overall group of substance users.
No takes yet. Share an insight, caveat, or question.
Campanile et al. (2022) conducted a cohort in First-episode infective endocarditis (n=379). ICD-10 substance use codes vs. Self-reported substance use (medical record review) was evaluated on Sensitivity, specificity, PPV, and NPV of ICD-10 substance use codes. ICD-10 substance use codes demonstrated high specificity and positive predictive value but low sensitivity, with the opioid code (F11) yielding a sensitivity of 42.6%.
Synapse has enriched 10 related papers. Consider them for comparative context: